Last updated: 2026-09-16 11:51:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $267.40, with a market capitalisation of $641.80B and a P/E ratio of 30.61. Over the past 52 weeks, its price has ranged from $173.33 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$641.80B | |
$266.29 | |
$281.07 | |
$46.25 | |
$267.20 | |
8.25K | |
7.60M | |
30.61 | |
$281.07 | |
$173.33 | |
1.96% | |
-- |
Johnson & Johnson (JNJ) is trading at $267.40 in pre-market trading as of 2026-09-16 11:49:00, up 0.07% ($0.20) from the previous close of $267.20
Pre-market trading shows how investors are pricing JNJ before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $275.23 to $267.40, representing a decline of 2.85% ($7.83).
The stock traded between $260.68 and $277.80 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 5.46 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87.3%
JNJ is currently trading at $267.40, placing it 87.3% of the way from its 52-week low of $173.33 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.